Reverse HER2-negative Immune Resistant Breast Cancer
Reverse HER2-negative Immune Resistant Breast Cancer
Recruiting · NCT06731140 · Registry updated 2025-11-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Reverse HER2-negative Immune Resistant Breast Cancer | HER2 Negative Breast Cancer | Recruiting | Phase 2 | 2025-11-17 | NCT06731140 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fudan University | 653 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan University Shanghai Cancer Center | Shanghai | China | 257 |